Lifeward

Global Aging And Robotics Integration Will Unlock New Markets

AnalystHighTarget

Not Invested

Consensus Narrative from 3 Analysts

Published

30 Aug 25

AnalystHighTarget's Fair Value

US$13.00

95.6% undervalued

30 Aug

US$0.57

-81.9%

-8.6%

-81.9%

-8.6%

Edit anytime before Aug 30 9:14 PM. Then post Updates to your followers.

Author's Valuation

US$13.0

95.6% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

US$13.0

95.6% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

38.83%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

9.43%

Calculation

US$50.63m

Earnings '28

11.61x

PE Ratio '28

US$587.86m

Market Cap '28

US$587.86m

Market Cap '28

34.50m

No. shares '28

US$17.04

Share Price '28

US$17.04 Share Price '28

Discounted to 2025 @ 9.44% p.a.

US$13.00

Fair Value '25